Analysis of risk factors for post-operative complications and prognostic predictors of disease recurrence following definitive treatment of patients with esophageal cancer from two medical centers in Northwest China
Jichang Wang(Shenyang Aerospace University), Xin Sun(Thomas Jefferson University), Guodong Xiao(First Affiliated Hospital of Xi'an Jiaotong University), Boxiang Zhang(Xinjiang Medical University), Jing Zhang(Fujian Medical University), Ning Du(First Affiliated Hospital of Xi'an Jiaotong University), Sida Qin(Harbin Medical University), Xiang Li(First Affiliated Hospital of Xi'an Jiaotong University), Gang Li(Qiqihar Medical University), Jinying Meng(Taiyuan University of Science and Technology), Hong Ren(First Affiliated Hospital of Xi'an Jiaotong University), Chongwen Xu(First Affiliated Hospital of Xi'an Jiaotong University), Shou‐Ching Tang(University of Mississippi Medical Center), Rui Liang(Nankai University), Jia Zhang(Shanxi Academy of Medical Sciences)
Cited by 12
Related Papers
ANG1005, a Brain-Penetrating Peptide–Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
|Clinical Cancer Research|2020|242
Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
|Journal of Experimental & Clinical Cancer Research|2019|141
Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
|Oncotarget|2015|107
Carbon Support Enhanced Mass Transfer and Metal–Support Interaction Promoted Activation for Low-Concentrated Nitric Oxide Electroreduction to Ammonia
|Journal of the American Chemical Society|2024|95
M6A associated TSUC7 inhibition contributed to Erlotinib resistance in lung adenocarcinoma through a notch signaling activation dependent way
|Journal of Experimental & Clinical Cancer Research|2021|92